Omeros (OMER) Free Cash Flow (2010 - 2026)
Omeros (OMER) reported Free Cash Flow of -$14.5 million for Q1 2026, up 59.57% on a YoY basis from -$9.1 million in Q1 2025, and up 63.59% sequentially from -$39.8 million in Q4 2025.
Omeros (OMER) Free Cash Flow (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Free Cash Flow data on file, last reported at -$14.5 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 59.57% year-over-year to -$14.5 million; the trailing twelve-month figure through Mar 2026 stood at -$94.8 million (up 33.72% YoY), and the FY2025 full-year result was -$116.2 million, up 22.02% from the prior year.
- Free Cash Flow climbed to -$14.5 million in Q1 2026, from -$39.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $174.5 million in Q1 2023 to a low of -$46.1 million in Q2 2024.
- A 5-year average of -$17.2 million and a median of -$29.0 million in 2024 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow jumped 1248.81% in 2023 and tumbled 123.97% in 2024, its largest moves.
- Tracing OMER's Free Cash Flow over 5 years: stood at -$25.4 million in 2022, then plunged by 37.6% to -$34.9 million in 2023, then grew by 16.99% to -$29.0 million in 2024, then tumbled by 37.36% to -$39.8 million in 2025, then surged by 63.59% to -$14.5 million in 2026.
- Business Quant data shows OMER's Free Cash Flow at -$14.5 million in Q1 2026, -$39.8 million in Q4 2025, and -$18.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | -14.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.51 Mn |
| Mar 31, 2026 | -14.51 Mn |
| Dec 31, 2025 | -39.84 Mn |
| Dec 31, 2025 | -39.84 Mn |
| Sep 30, 2025 | -18.48 Mn |
| Sep 30, 2025 | -18.48 Mn |
| Jun 30, 2025 | -21.95 Mn |
| Jun 30, 2025 | -21.95 Mn |
| Mar 31, 2025 | -35.88 Mn |
| Mar 31, 2025 | -35.88 Mn |
| Dec 31, 2024 | -29.01 Mn |
| Dec 31, 2024 | -29.01 Mn |
| Sep 30, 2024 | -32.06 Mn |
| Sep 30, 2024 | -32.06 Mn |
| Jun 30, 2024 | -46.07 Mn |
| Jun 30, 2024 | -46.07 Mn |
| Mar 31, 2024 | -41.84 Mn |
| Mar 31, 2024 | -41.84 Mn |
| Dec 31, 2023 | -34.94 Mn |
| Dec 31, 2023 | -34.94 Mn |